HIT Consultant May 21, 2024
What You Should Know:
– WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in ambulatory cardiac monitoring.
– The acquisition, coupled with a recent $6.7M funding round, positions WearLinq to significantly expand access to their innovative eWave 6-lead ECG monitor and revolutionize the fight against atrial fibrillation (AFib), which recently received FDA 510(k) clearance.
Tackling the Silent Threat of AFib
AFib, a heart rhythm irregularity, affects one in three people in their lifetime. It increases stroke risk fivefold and often leads to heart failure. Yet, current diagnostic methods miss a significant portion of cases, with over 30% of patients receiving false negatives and needing retesting within...
Today's Sponsors
Today's Sponsor